HT
IONS icon

HAP Trading’s Ionis Pharmaceuticals IONS Stock Holding History

HAP Trading’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,400
Closed -$44K – 1698
2022
Q3 		$44K Buy
+10,400
New +$438K ﹤0.01% 1018
2022
Q1 		– Sell
-16,800
Closed -$12K – 2503
2021
Q4 		$12K Buy
+16,800
New +$529K ﹤0.01% 1997
2018
Q2 		– Sell
-14,300
Closed -$4K – 1057
2018
Q1 		$4K Buy
14,300
+1,600
+13% +$81.3K ﹤0.01% 859
2017
Q4 		$6K Buy
+12,700
New +$696K ﹤0.01% 900
2017
Q2 		– Sell
-24,100
Closed -$39K – 1055
2017
Q1 		$39K Buy
24,100
+11,300
+88% +$508K ﹤0.01% 724
2016
Q4 		$84K Sell
12,800
-20,700
-62% -$819K ﹤0.01% 589
2016
Q3 		$63K Buy
33,500
+22,200
+196% +$695K ﹤0.01% 665
2016
Q2 		$9K Buy
+11,300
New +$365K ﹤0.01% 802

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HAP Trading's IONS Position: Q4 2021 in Review

HAP Trading sold out of Ionis Pharmaceuticals (IONS) in Q4 2021, closing a stake of 11,877 shares — an estimated $374K sold.

HAP Trading first reported a position in IONS in Q2 2013 and held it in 4 quarters. The position peaked at $2.14M in Q1 2019. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

  • HAP Trading reported no remaining Ionis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 11,877 Ionis Pharmaceuticals shares in Q4 2021, an estimated $374K.
  • HAP Trading first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • HAP Trading's Ionis Pharmaceuticals position peaked at $2.14M in Q1 2019.
  • 340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.